ÂÜÀòÂÒÂ×

Pawel Laskowski is a Senior Scientist at MSD since September 2021, specializing in regulatory milestones for global clinical submissions of biologics and development of CMC regulatory strategies. In addition, Pawel serves on the Supervisory Board at Polonium Foundation, overseeing activities and long-term strategy while also managing partnerships and organizing prominent scientific events. Previous experience includes a doctoral research role at ETH Zurich, focusing on biophysics and receptor-ligand interactions, as well as research assistant positions at the University of Chicago, where Pawel contributed to significant discoveries in protein aggregation, and the Max Planck Institute for Experimental Medicine, exploring neuroscience. Pawel holds a PhD in Biophysics from ETH Zurich and degrees in Biotechnology from the University of Warsaw.